A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection
Conditions: Hepatocellular Carcinoma Interventions: Drug: Sintilimab; Drug: Lenvatinib; Procedure: Transarterial Chemoembolization (TACE) Sponsors: Tongji Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Liver Cancer | Research | Study | Thrombosis